DOJ Reclassifies Marijuana, Building on President Trump’s Earlier E.O.

April 23, 2026
1:47 pm

▶

Listen to Article

President Trump's DOJ just dropped a bombshell by reclassifying marijuana under federal law, directly building on his bold 2025 executive order that set the wheels in motion for cannabis reform. This isn't some half-measure tweak—it's a seismic shift from Schedule I (the no medical use, high abuse potential club shared with heroin) toward Schedule III, acknowledging marijuana's accepted medical applications and lower risk profile. Trump's EO laid the groundwork by directing federal agencies to review outdated classifications, and now Attorney General Pam Bondi is delivering, citing mountains of state-level data, FDA approvals for cannabis-derived meds like Epidiolex, and a bipartisan push that's seen over 38 states legalize medical weed. Critics in the prohibition crowd are howling, but the science and public will have been screaming for this since the 1970 Controlled Substances Act lumped pot with the real hard stuff based on Nixon-era politics, not evidence. For the 2A community, this is a stealth win with massive ripple effects. We've long watched Big Brother wield the Controlled Substances Act as a backdoor gun control tool—ATF Form 4473 asks if you're an unlawful user of controlled substances, and a simple marijuana charge (even dismissed) can strip your rights under federal law, no conviction required. Reclassification neuters that pretext: millions of Americans who've toked legally under state law won't be federally branded as prohibited persons, potentially restoring 2A rights for veterans using CBD for PTSD, cancer patients on medical cannabis, or anyone caught in the crosshairs of Operation Chokepoint 2.0. Trump's move echoes his First Step Act criminal justice reforms, chipping away at federal overreach that disproportionately hammers red states and law-abiding gun owners. It's not full descheduling (yet), but it forces the ATF to rethink their unconstitutional marijuana user = felon stance, opening doors for lawsuits like those from the Second Amendment Foundation. The implications? Expect a flood of relief for the 2A base—think suppressed sales spiking as compliant citizens requalify for purchases—and a blueprint for future deregulatory strikes. This dovetails with Trump's pro-2A agenda, from appointing originalist judges to challenging Biden-era suppressors bans. Prohibitionists and gun-grabbers lose a key lever here; it's a reminder that when you peel back federal nanny-state layers, freedom expands across the Bill of Rights. Gun owners, stock up on that compliant ammo while you celebrate—this is momentum we can build on come 2026 midterms. Stay vigilant, stay armed.

Best FFL Software Ranked and Compared!

President Trump’s DOJ just dropped a bombshell by reclassifying marijuana under federal law, directly building on his bold 2025 executive order that set the wheels in motion for cannabis reform. This isn’t some half-measure tweak—it’s a seismic shift from Schedule I (the no medical use, high abuse potential club shared with heroin) toward Schedule III, acknowledging marijuana’s accepted medical applications and lower risk profile. Trump’s EO laid the groundwork by directing federal agencies to review outdated classifications, and now Attorney General Pam Bondi is delivering, citing mountains of state-level data, FDA approvals for cannabis-derived meds like Epidiolex, and a bipartisan push that’s seen over 38 states legalize medical weed. Critics in the prohibition crowd are howling, but the science and public will have been screaming for this since the 1970 Controlled Substances Act lumped pot with the real hard stuff based on Nixon-era politics, not evidence.

For the 2A community, this is a stealth win with massive ripple effects. We’ve long watched Big Brother wield the Controlled Substances Act as a backdoor gun control tool—ATF Form 4473 asks if you’re an unlawful user of controlled substances, and a simple marijuana charge (even dismissed) can strip your rights under federal law, no conviction required. Reclassification neuters that pretext: millions of Americans who’ve toked legally under state law won’t be federally branded as prohibited persons, potentially restoring 2A rights for veterans using CBD for PTSD, cancer patients on medical cannabis, or anyone caught in the crosshairs of Operation Chokepoint 2.0. Trump’s move echoes his First Step Act criminal justice reforms, chipping away at federal overreach that disproportionately hammers red states and law-abiding gun owners. It’s not full descheduling (yet), but it forces the ATF to rethink their unconstitutional marijuana user = felon stance, opening doors for lawsuits like those from the Second Amendment Foundation.

The implications? Expect a flood of relief for the 2A base—think suppressed sales spiking as compliant citizens requalify for purchases—and a blueprint for future deregulatory strikes. This dovetails with Trump’s pro-2A agenda, from appointing originalist judges to challenging Biden-era suppressors bans. Prohibitionists and gun-grabbers lose a key lever here; it’s a reminder that when you peel back federal nanny-state layers, freedom expands across the Bill of Rights. Gun owners, stock up on that compliant ammo while you celebrate—this is momentum we can build on come 2026 midterms. Stay vigilant, stay armed.

Share this story